Publication | Open Access
514MO Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2
15
Citations
0
References
2023
Year
MedicinePharmacologyAcquired MechanismsCancer Cell BiologyPathologyMolecular OncologyCancer TreatmentCancer GeneticsPreliminary DataOncologyTumor BiologyPlatinum-based Chemotherapy
No additional data available for this publication yet. Check back later!